The Future of Diagnostics is

Point-of-Care

Introducing Allegro's BioXMR™ platform, the first Point-of-Care technology that combines the sensitivity of a central lab with the speed and flexibility needed for modern medicine.

Lab Results at the Speed of Care

Today's diagnostic landscape forces a choice: get a fast answer, or get the complete answer. Point-of-care tests are often single-marker and lack sensitivity, while comprehensive lab panels are slow. To make confident, timely decisions, clinicians need both. They need a platform that delivers a full clinical picture with the accuracy of the central lab and the speed that modern care demands.

Innovation with Purpose: A New Architecture for Biological Sensing

Leveraging Allegro's decades of leadership in semiconductor sensor technology, the BioXMR™ platform represents a fundamental leap forward. By integrating our proven, high-sensitivity GMR sensors directly onto a monolithic silicon chip, we have created a powerful and scalable bio-assay platform. It is designed to rapidly and simultaneously quantify multiple proteins from a single small sample, delivering unprecedented insight right at the point of care.

  • High-Plex Capability: Simultaneously measure a wide array of biomarkers from a single drop of sample.

  • Exceptional Sensitivity: Utilizes Allegro's advanced, high-sensitivity GMR sensor technology for reliable detection of low-abundance targets.​

  • Point of Care Native: Our compact, low-cost reader and simple cartridge workflow deliver answers in under 30 minutes, fitting seamlessly into any clinical environment.

  • Flexible Platform: Our architecture and proprietary surface chemistry allow for the development of custom assay panels for specific applications.​

  • Semiconductor Scalability: Designed for high-volume, low-cost manufacturing on a proven semiconductor platform.

From Biology to Digital Data

BioXMR

 

Partner with Us to Shape the Future of Diagnostics